Sensor Patch Accurately Detects Atrial Fibrillation
By HospiMedica International staff writers Posted on 24 Nov 2021 |
Image: The wireless single-lead ECG247 heart sensor (Photo courtesy of Appsens AS)
An easy-to-use long-term electrocardiogram (ECG) sensor allows continuous outpatient recording of heart rhythms, with the diagnostic accuracy of a Holter monitor.
The Appsens AS (Lillesand, Norway) ECG247 heart sensor is a wireless single-lead ECG monitor that consists of an electrode patch with a lightweight reusable sensor, a smartphone application, a back-end cloud service, and a web portal. The water-resistant sensor attaches over the sternum and continuously monitors heart rhythm for up to 14 days without the need for charging. All ECG recordings are sent via Bluetooth Low Energy (BLE) communication through an app on the patient’s mobile phone to secure Microsoft Azure cloud storage, with web-access for the user and for healthcare professionals.
The ECG247 algorithms automatically detect and categorize cardiac arrhythmias using a multiple-step algorithm that analyzes the QRS complex as an adaptive process to ensure reliable detection; identify the correct beat type, based on a machine-learning algorithm that distinguishes between normal beats, supraventricular beats, ventricular beats, and artefacts; and analyze the arrhythmias or changes in rhythm to detect atrial flutter (AF), low/high heart rate, supraventricular tachycardia, ventricular tachycardia, and pauses.
“By detecting heart rhythm disorders early, ECG247 can help prevent serious complications such as stroke; 50,000 people [in Norway] with heart fibrillation are not aware of this because they have no symptoms,” said Tord Ytterdahl, managing director of Appsens AS. “At the moment, there is no product with the right technology that captures the large group of people who have this. Many people who feel palpitations from time to time can now easily test themselves.”
The original Holter monitor, named for physicist Norman J. Holter who invented telemetric cardiac monitoring in 1949, is a portable device for continuously monitoring various electrical activity of the cardiovascular system for at least 24 hours (often for two weeks at a time). Its extended recording period is useful for observing occasional cardiac arrhythmias which would be difficult to identify in a shorter period of time.
Related Links:
Appsens AS
The Appsens AS (Lillesand, Norway) ECG247 heart sensor is a wireless single-lead ECG monitor that consists of an electrode patch with a lightweight reusable sensor, a smartphone application, a back-end cloud service, and a web portal. The water-resistant sensor attaches over the sternum and continuously monitors heart rhythm for up to 14 days without the need for charging. All ECG recordings are sent via Bluetooth Low Energy (BLE) communication through an app on the patient’s mobile phone to secure Microsoft Azure cloud storage, with web-access for the user and for healthcare professionals.
The ECG247 algorithms automatically detect and categorize cardiac arrhythmias using a multiple-step algorithm that analyzes the QRS complex as an adaptive process to ensure reliable detection; identify the correct beat type, based on a machine-learning algorithm that distinguishes between normal beats, supraventricular beats, ventricular beats, and artefacts; and analyze the arrhythmias or changes in rhythm to detect atrial flutter (AF), low/high heart rate, supraventricular tachycardia, ventricular tachycardia, and pauses.
“By detecting heart rhythm disorders early, ECG247 can help prevent serious complications such as stroke; 50,000 people [in Norway] with heart fibrillation are not aware of this because they have no symptoms,” said Tord Ytterdahl, managing director of Appsens AS. “At the moment, there is no product with the right technology that captures the large group of people who have this. Many people who feel palpitations from time to time can now easily test themselves.”
The original Holter monitor, named for physicist Norman J. Holter who invented telemetric cardiac monitoring in 1949, is a portable device for continuously monitoring various electrical activity of the cardiovascular system for at least 24 hours (often for two weeks at a time). Its extended recording period is useful for observing occasional cardiac arrhythmias which would be difficult to identify in a shorter period of time.
Related Links:
Appsens AS
Latest Critical Care News
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing